Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Unknown 2Recruiting 2Active not recruiting 2Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2Genitourinary 1

Conditions

Carcinoma, Hepatocellular 36Carcinoma, Non-Small-Cell Lung 17Small Cell Lung Carcinoma 16Neoplasms 14Lung Neoplasms 13Breast Neoplasms 7Melanoma 6Colorectal Neoplasms 6Carcinoma, Renal Cell 6Liver Neoplasms 5Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Prostatic Neoplasms 4Neoplasm Metastasis 4Head and Neck Neoplasms 4Glioblastoma 4Endometrial Neoplasms 4Sarcoma 3Recurrence 3Neoplasms by Site 3Neoplasms by Histologic Type 3Carcinoma, Transitional Cell 3Uterine Cervical Neoplasms 2Urogenital Neoplasms 2Small Cell Lung Cancer Extensive Stage 2Sarcoma, Alveolar Soft Part 2Ovarian Neoplasms 2Osteosarcoma 2Mesothelioma, Malignant 2Mesothelioma 2

Interventions

Pemetrexed 4Cisplatin 4pembrolizumab 3Nivolumab 3Interleukin-2 3Carboplatin 3atezolizumab 2aldesleukin 2Pharmaceutical Preparations 2Ipilimumab 2olaparib 1lenvatinib 1fludarabine 1enzalutamide 1Thoracoscopy 1Thoracic Surgery, Video-Assisted 1Surgery, Computer-Assisted 1Proton Therapy 1Platinum 1Paclitaxel 1Injections 1Influenza Vaccines 1Indocyanine Green 1In Situ Hybridization, Fluorescence 1Cyclophosphamide 1Combined Modality Therapy 1Cerebral Decortication 1Brentuximab Vedotin 1Blood Component Removal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Mesothelioma, Malignant × atezolizumab × Clear all
NCT04996017 2025-03-13

AtezoMeso

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 3 Recruiting
162 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT05765084 2024-05-16

Immuno-MESODEC

University Hospital, Antwerp

Phase 1/2 Recruiting
15 enrolled
GenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡